EUVIMEDEUVIMED entdecken
Crossref

Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies

Azamat KM Azamat, MD Rafi Haider, Wasim Akhtar, Bhupendra Chauhan, Naveen Kumar, Zulphikar Ali

Drug Discovery and Development · 17.04.2026 · 2 (1) · 1-16

DOI: 10.5530/ddd.2.1.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Discovery and Development, online erschienen am 17.04.2026. Verfasst von Azamat KM Azamat und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Azamat, A. K., Haider, M. R., Akhtar, W., Chauhan, B., Kumar, N., & Ali, Z. (2026). Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies. Drug Discovery and Development, 2(1), 1-16. https://doi.org/10.5530/ddd.2.1.1

Vancouver

Azamat AK, Haider MR, Akhtar W, Chauhan B, Kumar N, Ali Z. Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies. Drug Discovery and Development. 2026;2(1):1-16. doi:10.5530/ddd.2.1.1

BibTeX
@article{Azamat2026,
  author = {Azamat, Azamat KM and Haider, MD Rafi and Akhtar, Wasim and Chauhan, Bhupendra and Kumar, Naveen and Ali, Zulphikar},
  title = {Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies},
  journal = {Drug Discovery and Development},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {1--16},
  doi = {10.5530/ddd.2.1.1}
}
Kostenlos starten →